Market Value Added

(redirected from MVA)
Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.

Market Value Added

The difference between the market value of an asset or company and the capital that shareholder or other investors have invested into it. A positive MVA means that the asset or company has increased in value while a negative MVA indicates the opposite. Obviously, an investor wants the highest MVA possible for his/her investments.
Mentioned in ?
References in periodicals archive ?
MVA calculations determine the lifetime costs of posting initial margin as part of the pricing of an OTC derivative.
Conclusion: MVA is as safe and effective as DandC for the management of miscarriage.
Subsequently, there have been very little research conducted on MVA in Asian countries, including Malaysia (Al Mamun & Abu Mansor, 2012; Sharma & Kumar, 2010).
Professor Adrian Hill, director of the Jenner Institute at Oxford University, said, "Production of the first ever batch of MVA for a clinical trial using a cell line is a milestone in the development of this important vaccine technology.
MVA data further showed that crashes reduced by 20%, injuries reduced by 12% and fatalities increased by 62%.
RESULT: In this study included 200 women selected for first trimester MTP during 1 year period 100 women underwent for MTP by MVA method (group I) & 100 women underwent with S & E method (group II) In MVA group 9% were < 20 yrs, 24 were % 20-24 yrs, 38% were 25-29 yrs and in S & E group 10% were < 20 yrs, 25% were 20-24 yrs, 40% were 25-29 yrs, 18% were 30-34 yrs.
Earlier in December 2011, Voltamp Power received an approval from DCRP, Oman for 20 MVA 33/11.
An MVA system takes process signals, such as melt pressure, screw position, barrel temperature, melt temperature, mold closing, filling, pack/hold, and cooling.
I recently received statements from 2 prominent insurance companies showing their customers that they would lose in excess of 30% of their fixed index annuity principal because of surrender charges and the MVA in their products.
MVA is related to the more widely known Economic Value Added[TM] (EVA).
The USPTO's patent grant to the MVA-BN[R] virus which is non-replicative in humans acknowledges the novelty and utility of such a virus exhibiting the demonstrated excellent safety profile of the MVA-BN[R] technology and other claimed MVA viruses exhibiting similar characteristics.